<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972037/" ref="ordinalpos=3394&amp;ncbi_uid=5964245&amp;link_uid=PMC3972037" image-link="/pmc/articles/PMC3972037/figure/F4/" class="imagepopup">Fig. 4.  From: PTEN Loss Does Not Predict for Response to RAD001 (Everolimus) in a Glioblastoma Orthotopic Xenograft Test Panel. </a></div><br /><div class="p4l_captionBody">Western blot analysis of mTOR signaling. Flank tumor specimens were evaluated for activation of the mTOR signaling pathway by Western blotting with phosphorylation-specific and nonphosphorylation antibodies as indicated.</div></div>